Docket Room
S 4054·NJ·senate

Clarifies that testosterone therapy is covered treatment under the "New Jersey Menopause Coverage Act."

In CommitteeFiled Mar 23, 2026
Sponsor: Burzichelli, John J.
Latest Action

Introduced First Reading Senate Referred to SCM

Mar 23, 2026

Summary

S4054 amends the Menopause Coverage Act to require health‑insurance contracts to cover testosterone therapy as a medically necessary hormonal treatment for women in perimenopause or menopause. The amendment applies to hospital, medical and health service corporation contracts and mandates that coverage be provided on the same terms as other hormone therapies, even if the FDA has not approved testosterone for these conditions.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when S 4054 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice